Open AccessBenefits of Selumetinib in NF1-Associated Plexiform Neurofibromas
Author(s) -
Mark L. Fuerst
Publication year - 2019
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000618272.74700.ea
Subject(s) - neurofibromatosis , medicine , plexiform neurofibroma , selumetinib , neurofibromatosis type 2 , debulking , cancer , oncology , surgery , neurofibroma , pathology , ovarian cancer , colorectal cancer , kras
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom